UCL Brain Cancer Seminar Series

Thu Jun 15 2023 at 12:00 pm to 01:00 pm

33 Queen Square | London

UCL
Publisher/HostUCL
UCL Brain Cancer Seminar Series
Advertisement
Creating a community of interdisciplinary scientists and clinicians, working on translational research projects to cure brain cancer.
About this Event
We warmly invite you to join us for the UCL Brain Cancer Seminar Series

The seminars will be an opportunity to bring together the research community across UCL (QS IoN, GOSH-ICH, and the CI), NHS Trusts (UCLH, GOSH), and the Francis Crick Institute, alongside our wider national & global partners - including University of Toronto. We will use these seminars to raise the researcher profile, foster engagement and encourage networking across research groups working in areas related to brain cancer, across diverse disciplines, including engineering, machine learning, and basic biology through to clinical studies. The seminars will provide a platform for knowledge exchange and transfer to help facilitate cross collaborative projects across the breadth of the translational pipeline, to lead and support cutting-edge research in brain tumour biology, novel diagnostic methods, and new therapies, in our mission to cure brain cancer.


We have a special seminar in the series for 2022/23, which will be hosted on Thursday 15th June 2023, at 12:00 - 13:00 BST (U.K)

Zoom details will be shared shortly with all registered attendees

Or

If you would like to attend in person, the venue details are: 33 Queen Square, Basement Lecture Theatre


EVENT DETAILS

Introduction: Jeremy Rees - Consultant Neurologist

Guest Presenter : Soma Sengupta

Presentation: GABA-A receptors in cancer, followed by Q&A/discussion

About the Guest Presenter

Soma Sengupta completed her MD-PhD at the University of Cambridge, U.K. She received Membership in the Royal College of Physicians (U.K.) before moving to the U.S. for an internship in medicine, residency in Neurology Beth Israel Deaconess Medical Center-Harvard; and clinical and research fellowships in neuro-oncology at Massachusetts General Hospital, Boston Children’s Hospital, Dana-Farber Cancer Institute, and Brigham and Women’s Hospital. She is fellowship trained in Integrative Medicine from the Andrew Weil Integrative Medicine Center, University of Arizona. Soma Sengupta is board certified in Neurology and Neuro-Oncology she is currently doing an MBA at the University of Cincinnati; both are online programs. She was elected as a Fellow of the Royal College of Physicians (FRCP), London, U.K.

Soma Sengupta’s Post-doctoral research training included a fellowship at Yale with Prof. Carolyn Slayman (deceased); training in immunology research at the Cambridge Institute of Medical Research (U.K.) with Dr. Paul Lehner, and training in pediatric brain tumor research with Drs. Scott Pomeroy at Boston Children’s Hospital and Frances Jensen (currently Chair, Dept. Neurology, Univ. of Pennsylvania).

Soma Sengupta was an attending at BIDMC-Harvard in neuro-oncology before moving to Emory Univ. and the Winship Cancer Institute. She has a long-standing research interest in membrane transport proteins. A major part of her lab studies proteins as anti-cancer targets and their role in developing disparate cancers. Clinically, Soma Sengupta manages adult brain tumors and adult survivors of pediatric brain cancers. She has a strong clinical interest in investigator-initiated trials to bring much-needed new treatments for these patient populations.

For further information about the UCL Brain Cancer Seminar Series, or if you would like to present at future seminars, please contact Morium Ali (BRC Neuro-Oncology Coordinator) - [email protected]

Advertisement

Event Venue & Nearby Stays

33 Queen Square, 33 Queen Square, London, United Kingdom

Tickets

GBP 0.00

Sharing is Caring: